Table 1.
Partnership characteristics and injection and sex behaviors in the past month within partnerships at baseline interview (n = 72).
| Partnership characteristic | HCV− partner n (%)/median (IQR) | HCV+ partner n (%)/median (IQR) |
|---|---|---|
| Number of months has known partner | 12 (5–24) | 12 (5.5–36) |
| Number of months injected with partner | 6 (2–12) | 6 (2–18) |
| Live with partner | 56 (77.8) | 51 (72.9) |
| Number of days cohabitation (if live togethera) | 15 (4–28.5) | 15 (5–28) |
| Stable housing (if live togethera) | 11 (20.0) | 10 (19.2) |
| Number of days injected together | 15 (8–23) | 14 (7–30) |
| Number of times injected together per day | 2 (1.5–3) | 2 (2–3.5) |
| Number of other people partner injects with | 3 (2–5) | 3 (1–9) |
| Always pool money to buy drugs | 34 (47.2) | 36 (50.7) |
| Used a contaminated cooker | 19 (27.5) | 26 (38.2) |
| Used a syringe backloaded by partner | 40 (56.3) | 46 (64.8) |
| Injected partner’s rinse | 28 (38.9) | 36 (51.4) |
| Injected partner (always or usually) | 5 (6.9) | 14 (20.0) |
| Was injected by partner (always or usually) | 11 (15.3) | 3 (4.2) |
| Injected with a needle partner already used | 10 (14.5) | 21 (30.4) |
| Partner injected with a needle you already used | 18 (26.1) | 11 (16.9) |
| Vaginal or anal sex with partner | 27 (37.5) | 28 (39.4) |
a
N for living together = 56 for HCV− partners and 51 for HCV+ partners.